Global Absorbable Heart Stent Market to Reach USD 931.44 Million by 2031 | CAGR of 13.1%
Category : Healthcare | Published Date : Nov 2024 | Type : Press Release
Absorbable Heart Stent Market Scope & Overview:
In the newly published report, Consegic Business Intelligence states that the Absorbable Heart Stent Market was valued at USD 346.73 Million in 2023 and is projected to reach USD 931.44 Million by 2031, growing at a CAGR of 13.1% from 2024 to 2031. Absorbable heart stents, or bioresorbable stents, are specialized medical devices used in the treatment of blocked coronary arteries. Unlike conventional metal stents, these stents dissolve over time, reducing long-term risks associated with permanent implants, such as vessel scarring and restenosis. Made from materials like polylactic acid, absorbable stents offer temporary support to arteries, facilitating natural healing and minimizing complications over time.
The report comprises the Absorbable Heart Stent Market Share, Size & Industry Analysis, By Material Type (Polymer-Based Stents, Metal-Based Stents), By Absorption Rate (Fast Absorption Stents, Slow Absorption Stents), By Application (Coronary Artery Disease, Peripheral Artery Disease), By End User (Hospitals, Ambulatory Surgical Centers (ASCs), Cardiac Centers, Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), and Forecast, 2024-2031.
The report contains detailed information on Absorbable Heart Stent Market Trends, Opportunities, Value, Growth Rate, Segmentation, Geographical Coverage, Company Profile, In-depth Expert Analysis, Revenue Forecast, Competitive Landscape, Growth Factors, Restraints or Challenges, Environment & Regulatory Landscape, PESTLE Analysis, PORTER Analysis, Key Technology Landscape, Value Chain Analysis, and Cost Analysis.
Increasing preference for absorbable stents over metal stents is a key driver, while safety concerns and limited clinical evidence of long-term efficacy present constraints.
Segmental Analysis :
By material type, the market is segmented into polymer-based and metal-based stents.
- Polymer-based stents held the largest market share in 2023, driven by their biocompatibility and natural degradation within the body.
- Metal-based stents are anticipated to grow at the fastest CAGR, supported by their rapid degradation properties and strong initial support.
By absorption rate, the market is segmented into fast absorption and slow absorption stents.
- Fast absorption stents accounted for the largest share in 2023, as they provide temporary support and minimize risks such as chronic inflammation.
- Slow absorption stents are expected to register the fastest CAGR due to their extended support, ideal for high-risk patients requiring prolonged arterial patency.
By application, the market is segmented into coronary artery disease and peripheral artery disease.
- Coronary artery disease (CAD) was the largest segment in 2023, driven by the high incidence of CAD globally.
- Peripheral artery disease is expected to grow at the fastest rate, as absorbable stents provide temporary support, reducing complications in these complex cases.
By end-user, the market is segmented into hospitals, ASCs, cardiac centers, and others.
- Hospitals dominated the market in 2023, being the primary settings for cardiovascular interventions.
- Ambulatory Surgical Centers (ASCs) are projected to grow at the fastest rate due to cost-effectiveness and shorter patient stays.
Based on regions, the global market is segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
- North America led the market in 2023 due to advanced cardiovascular care infrastructure and high CAD prevalence.
- Asia-Pacific is expected to witness the fastest CAGR, driven by rising healthcare investments and the high incidence of cardiovascular diseases.
| Report Attributes | Report Details |
| Study Timeline | 2018-2031 |
| Market Size in 2031 | USD 931.44 Million |
| CAGR (2024-2031) | 13.1% |
| By Material Type | Polymer-Based Stents, Metal-Based Stents |
| By Absorption Rate | Fast Absorption Stents, Slow Absorption Stents |
| By Application | Coronary Artery Disease, Peripheral Artery Disease |
| By End User | Hospitals, ASCs, Cardiac Centers, Others |
| By Region | North America(U.S., Canada, Mexico) Europe(U.K., Germany, France, Spain, Italy, Russia, Benelux, Rest of Europe) APAC(China, South Korea, Japan, India, Australia, ASEAN, Rest of Asia-Pacific) Middle East & Africa(GCC, Turkey, South Africa, Rest of MEA) LATAM(Brazil, Argentina, Chile, Rest of LATAM) |
Top Key Players & Competitive Landscape :
The absorbable heart stent market is competitive, with major players focusing on R&D and product innovation.
List of prominent players in the Absorbable Heart Stent Industry:
- Abbott Laboratories (USA)
- Boston Scientific Corporation (USA)
- Medtronic plc (Ireland)
- BIOTRONIK SE & Co. KG (Germany)
- Terumo Corporation (Japan)
- Elixir Medical Corporation (USA)
- REVA Medical, Inc. (USA)
- Arterial Remodeling Technologies (France)
- Kyoto Medical Planning Co., Ltd. (Japan)
- Amaranth Medical, Inc. (USA)
Recent Industry Developments :
- In April 2024, Abbott's FDA-approved Esprit™ BTK dissolvable stent improves outcomes for treating chronic limb-threatening ischemia (CLTI) below-the-knee, offering better results than balloon angioplasty.
